Quantification of TMEM158 expression in tumor and normal tissue samples of 60 individuals with primary breast cancer showed that, although TMEM58 expression is suppressed in 23% of tumors, it was upregulated in 15% 11, suggesting it may not be an oncogene in breast cancer. Here, SHISA4 is linked to breast cancer.